**Question:** A patient tested positive for MTB on sputum CBNAAT. He did not come again to PHC in spite of multiple reminders. He now presents with non-massive hemoptysis and is alarmed. What is the next best step for this patient?

A. Initiate anti-TB treatment without further investigations
B. Advise the patient to seek immediate medical attention, explaining the potential severity of the situation
C. Discuss the need for further investigations and treatment options
D. Ignore the patient's concerns and reassure them about the mild nature of their symptoms

**Correct Answer:** B.

**Core Concept:**
The question is addressing the management of a patient with a past TB diagnosis confirmed by CBNAAT, presenting with hemoptysis and increased anxiety due to non-adherence to treatment and lack of follow-up. These patients require a nuanced approach considering the severity of the situation and their past behavior.

**Why the Correct Answer is Right:**
The correct answer, option B, addresses the patient's concerns and emphasizes the potential severity of the situation. It advises the patient to seek immediate medical attention, explaining the significance of their symptoms and the importance of adherence to treatment for a better prognosis. In this case, the patient's non-adherence to treatment and lack of follow-up puts them at high risk for severe complications, including hemoptysis.

**Why Each Wrong Option is Incorrect:**

A. Initiating treatment without further investigations: This option is incorrect because it does not consider the severity of the patient's symptoms and the potential complications of untreated TB. Further investigations are essential to confirm the diagnosis and guide appropriate treatment.

B. Ignoring the patient's concerns and reassuring them about mild symptoms: This option is unsuitable as it does not address the patient's fears and non-adherence, which could lead to worsening health outcomes.

C. Discussing further investigations and treatment options: Although discussing investigations is important, the patient's non-adherence and hemoptysis raise concerns about the severity of their condition. Addressing these factors and reassuring the patient about the need for treatment is crucial.

**Clinical Pearls:**

1. Non-adherence and non-attendance to follow-up appointments in a patient with previous TB diagnosis and active hemoptysis is concerning.
2. In such cases, the healthcare provider must prioritize addressing the patient's fears, reassuring them about the severity of symptoms, and emphasizing the need for adherence to treatment.
3. Thorough evaluation and appropriate management plan must be established, including confirmation of the diagnosis via sputum culture and drug sensitivity testing (CDST) and initiation of anti-TB treatment, including isoniazid, rifampicin, pyrazinamide, and ethambutol, for four months (phase 1) followed by isoniazid and rifampicin for the next four months (phase 2).
4. Regular follow-ups, including sputum culture and drug sensitivity tests, are essential to monitor treatment response and adjust the treatment plan as needed.
5. Instructing the patient about the importance of adherence, regular